Alembic Pharmaceuticals advanced 2.94% to Rs 1,011.20 after it received tentative approval from the US Food & Drug Administration (US FDA) for Ribociclib tablets.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
Alembic Pharmaceuticals advanced 2.94% to Rs 1,011.20 after it received tentative approval from the US Food & Drug Administration (US FDA) for Ribociclib tablets.
| Subscribe To Our Free Newsletter |
